The Mechanism of Action of Nitro-heterocyclic Antimicrobial Drugs. Primary Target of 1-Methyl-2-nitro-5-vinylimidazole is DNA
- 1 June 1977
- journal article
- research article
- Published by Microbiology Society in Journal of General Microbiology
- Vol. 100 (2) , 271-281
- https://doi.org/10.1099/00221287-100-2-271
Abstract
Summary The antimicrobial drug 1-methyl-2-nitro-5-vinylimidazole (MEV) preferentially blocked DNA synthesis, was mutagenic and induced coliphage λ in Escherichia coli. The antibacterial effects of MEV are the consequences of repairable damage to DNA, as shown by hypersensitivity of recA and uvr strains to MEV and related drugs, stimulation by MEV of DNA turnover which was dependent on the product of the uvrA gene, and the presence of cross-links in DNA from MEV-treated bacteria.This publication has 5 references indexed in Scilit:
- The Mechanism of Action of Nitro-heterocyclic Antimicrobial Drugs. Metabolic Activation by Micro-organismsJournal of General Microbiology, 1977
- Abnormal metabolic response to ultraviolet light of a recombination deficient mutant of Escherichia coli K12Journal of Molecular Biology, 1966
- Nitrofurazone as a mutagen in EscherichiacoliBiochemical and Biophysical Research Communications, 1964
- A procedure for the isolation of deoxyribonucleic acid from micro-organismsJournal of Molecular Biology, 1961
- MUTANTS OF ESCHERICHIA COLI REQUIRING METHIONINE OR VITAMIN B 12Journal of Bacteriology, 1950